NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study)

Active Not RecruitingNA

Sponsor: University Health Network, Toronto

Conditions: Myocardial Injury, Myocarditis, COVID-19 Vaccination, SARS-CoV-2, Cardiac MRI

Interventions: Cardiac PET/MRI, Blood Biomarkers

Countries: Canada

The study will focus on cardiac blood and imaging biomarkers to facilitate early recognition of patients at risk for myocardial injury after COVID-19 vaccination. Ultimately, the intention is to identify patients at risk, reduce adverse events, and determine the need for longer-term follow-up in patients with myocardial injury after vaccination.

Eligibility overview

Sex: ALL

Age: 17 Years to —

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

1. Age ≥ 17 years (both Cohort A and B)
2. Received at least one dose of a COVID-19 vaccine in the past 6 months (both Cohort A and B)
3. Developed new clinical signs or symptoms suggestive of myocarditis/myocardial injury within one month of COVID vaccine administration without other known cause (Cohort A, only)

Exclusion Criteria:

1. Contraindications to cardiac PET/MRI
2. Current history of COVID-19

Locations (1)

Toronto, Ontario, Canada